Legend Biotech Corp (LEGN) Operating margin 2023–2025
Legend Biotech Corp (LEGN) operating margin by fiscal year — reported operating income divided by reported revenue.
-13.3%FY2025 · since FY2023: -185.2% → -13.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -13.3% | +36.1 pp |
| FY2024 | -49.3% | +135.9 pp |
| FY2023 | -185.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More LEGN financial trends
LEGN RevenueLEGN Net incomeLEGN Net marginLEGN Gross profitLEGN Gross marginLEGN Operating incomeLEGN Operating cash flowLEGN Free cash flowLEGN Capital expendituresLEGN Return on equityLEGN Stock buybacksLEGN Dividends paidLEGN Total assetsLEGN Total liabilitiesLEGN Shareholders’ equityLEGN overview →